Fortis Healthcare

Fortis Healthcare

845.55
-1.00
(-0.12%)
ann
There are new updates from the company22 hours ago
Viewcross
right
Market Cap
63,911.00 Cr
EPS
10.26
PE Ratio
75.81
Dividend Yield
0.12 %
52 Week High
849.70
52 Week Low
480.55
PB Ratio
7.17
Debt to Equity
0.22
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from12 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Fortis Hospotel Limited, a wholly-owned subsidiary of Fortis Healthcare Limited, has completed the acquisition of Shrimann Superspecialty Hospital's entire business operations. The transaction includes the hospital land and adjacent property. The acquisition was completed at 09:14 PM IST on July 24, 2025, following earlier intimations to exchanges in February, March, and May 2025 regarding the definitive agreements for this transaction.
positive
Fortis Healthcare shares reached a new record high of Rs 839.90 after IHH Healthcare Berhad signed an operation and maintenance services agreement with the company. Under the agreement, Fortis Healthcare will operate and maintain five out of six Gleneagles hospitals across India. The collaboration aims to strengthen IHH Healthcare Berhad's business in India and unlock operational and financial synergies across both networks. Fortis shares rose 1.97% to the record high and were trading 0.89% higher at Rs 831, outperforming the NSE Nifty 50 which declined 0.13%. The stock has gained 72.03% over 12 months and 15.62% year-to-date. Trading volume was 3.8 times the 30-day average. Among 15 analysts covering the stock, 14 maintain buy ratings while one suggests sell, with the average 12-month price target implying a 2.4% downside.
positive
Fortis Healthcare Shares Rise on O&M Agreement with Gleneagles Healthcare India2 days ago
Fortis Healthcare signed an operation and management services agreement with Gleneagles Healthcare India (GHIPL) covering five hospitals and one clinic. Under the deal, Fortis will receive a monthly service fee equal to 3% of the net revenue from GHIPL's hospitals business, which had consolidated revenue of ₹718.5 crore as of March 31, 2025. The agreement becomes effective for Gleneagles BGS Hospital in Karnataka. GHIPL is a subsidiary of IHH, which is the parent entity of Fortis' promoter. The partnership expands Fortis' geographic footprint, increases beds under management, and provides incremental revenue through direct service fees. GHIPL will cover all third-party and out-of-pocket expenses incurred by Fortis. Fortis Healthcare shares traded 1.09% higher at ₹817.9, with the stock gaining 15.3% year-to-date.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,280.50
#1 1,23,209.90
108.87
7,184.10
18.77
1,076
26.84
58.90
7,468.50
1,05,875.80
73.24
#1 21,794.00
14.74
1,513
60.41
59.91
845.55
#3 63,911.00
#6 75.81
#2 7,849.70
#10 8.99
#4 809
#8 -7.43
69.70
1,991.60
40,475.70
50.87
5,482.98
10.96
807
3.41
53.26
1,323.10
35,620.10
68.53
3,692.32
#1 25.09
486
-20.35
65.64
761.95
31,585.00
83.81
3,035.10
12.94
409
48.39
64.31
582.40
30,830.80
83.07
4,138.46
22.85
#1 5,417
#1 3,986.36
45.17
1,556.40
16,491.00
69.34
1,566.90
17.46
244
10.57
55.29
1,453.90
9,575.90
#1 50.85
1,290.20
17.77
194
-0.88
41.56
570.00
7,826.80
176.00
2,218.14
12.97
28
-71.06
55.67

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
29.44 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
1,085
1,152
1,150
1,024
1,106
1,176
1,257
1,630
1,164
1,229
1,258
1,175
1,108
1,081
1,156
1,164
1,528
1,170
1,277
1,178
1,133
614
1,029
1,205
1,278
1,733
1,475
1,487
1,391
1,519
1,682
1,586
1,669
1,667
1,788
1,699
1,803
1,873
2,006
1,975
2,032
Expenses
1,022
986
1,087
1,066
1,091
1,059
1,097
1,023
1,045
1,071
1,138
1,069
1,907
1,034
1,172
1,193
1,069
996
1,028
1,012
987
709
875
987
1,055
1,135
1,178
1,180
1,157
1,237
1,304
1,283
1,372
1,386
1,440
1,396
1,405
1,516
1,613
1,553
1,625
EBITDA
62
166
62
-42
15
118
160
607
118
158
120
106
-799
47
-16
-29
459
174
250
166
146
-96
155
218
223
598
297
307
234
282
378
302
297
282
349
303
398
356
393
422
406
Operating Profit %
3 %
4 %
-2 %
-5 %
-2 %
6 %
8 %
10 %
7 %
7 %
5 %
5 %
-76 %
1 %
-3 %
-8 %
10 %
13 %
15 %
13 %
11 %
-17 %
12 %
16 %
16 %
20 %
19 %
20 %
16 %
17 %
19 %
18 %
16 %
16 %
19 %
17 %
21 %
18 %
19 %
19 %
19 %
Depreciation
61
53
0
0
72
48
52
60
63
59
61
59
60
57
56
60
60
71
71
70
80
72
74
73
72
73
75
76
77
74
77
83
82
79
84
87
92
91
95
97
102
Interest
37
34
30
32
38
42
46
75
67
64
66
63
64
76
85
111
65
51
49
48
57
41
42
42
41
38
40
38
30
31
33
33
32
32
32
33
35
35
36
45
68
Profit Before Tax
-22
88
44
-58
-96
28
62
472
-11
35
-7
-17
-924
-87
-157
-201
334
52
130
48
9
-208
38
103
110
486
182
193
126
176
268
186
183
171
233
183
271
230
261
279
237
Tax
-10
-9
-17
-29
-8
3
24
19
26
12
17
3
-9
-34
-15
-20
183
-26
6
118
50
-20
23
49
48
56
51
51
39
42
50
44
45
47
49
49
68
56
68
25
49
Net Profit
-12
97
61
-29
-88
25
38
453
-38
23
-24
-19
-914
-53
-142
-180
151
78
124
-69
-41
-188
16
54
62
431
131
142
87
134
218
142
138
124
184
134
203
174
193
254
188
EPS in ₹
-0.38
2.01
1.19
-0.65
-1.91
0.35
0.68
9.49
-0.79
0.10
-0.88
-0.71
-17.97
-1.36
-3.21
-3.06
1.80
0.90
1.47
-1.01
-0.59
-2.37
-0.05
0.40
0.57
3.49
1.42
1.55
0.90
1.62
2.71
1.72
1.76
1.48
2.30
1.78
2.37
2.20
2.34
3.28
2.44

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Fixed Assets
4,218
3,776
5,419
4,992
8,477
8,802
8,799
9,416
9,426
9,874
10,424
Current Assets
1,636
1,434
1,775
1,282
1,667
941
1,037
1,133
1,406
1,421
1,471
Capital Work in Progress
228
201
268
226
450
204
165
194
228
542
407
Investments
616
1,449
1,878
1,732
270
175
186
104
210
230
169
Other Assets
2,554
1,807
2,152
1,672
2,755
2,167
2,005
2,172
2,569
2,643
2,692
Total Liabilities
7,616
7,232
9,717
8,622
11,951
11,348
11,155
11,885
12,434
13,289
13,692
Current Liabilities
1,602
1,476
1,927
2,134
3,591
2,579
1,233
1,269
1,426
3,170
1,607
Non Current Liabilities
1,813
1,616
1,480
1,171
1,248
1,563
3,204
3,607
2,907
1,563
2,915
Total Equity
4,201
4,140
6,311
5,317
7,113
7,206
6,718
7,008
8,100
8,556
9,169
Reserve & Surplus
3,585
3,534
4,626
3,543
5,846
5,906
5,365
5,423
6,487
6,908
8,162
Share Capital
463
463
518
519
755
755
755
755
755
755
755

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-66
-38
225
-513
799
-627
212
-153
-22
125
-70
Investing Activities
213
122
-1,001
-333
-3,279
64
-131
-501
-373
-889
-780
Operating Activities
24
195
967
493
-179
172
486
865
822
1,100
1,424
Financing Activities
-304
-354
259
-672
4,257
-862
-143
-517
-471
-87
-714

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
31.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
26.32 %
0.00 %
23.24 %
23.31 %
25.26 %
26.77 %
27.40 %
27.17 %
DIIs
13.44 %
15.20 %
15.66 %
15.50 %
16.72 %
17.44 %
19.94 %
20.38 %
20.70 %
22.16 %
26.55 %
29.35 %
31.15 %
32.31 %
30.73 %
30.05 %
29.46 %
29.79 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.96 %
15.16 %
15.98 %
14.89 %
13.96 %
13.58 %
12.92 %
12.39 %
12.05 %
11.80 %
11.13 %
11.04 %
10.82 %
10.47 %
10.36 %
10.21 %
10.22 %
10.17 %
Others
41.43 %
38.47 %
37.20 %
38.44 %
38.15 %
37.82 %
35.98 %
36.06 %
36.08 %
34.86 %
4.83 %
28.44 %
3.63 %
2.75 %
2.48 %
1.81 %
1.75 %
1.70 %
No of Share Holders
0
1,09,889
1,44,634
1,66,743
1,54,572
1,56,881
1,60,762
1,58,455
1,37,894
1,35,047
1,31,516
1,35,664
1,57,165
1,54,260
2,04,184
2,21,750
2,18,329
2,05,373

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.14 0.12

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Aug 2025 773.45 846.55
25 Jul 2025 DIVIDEND Dividend
₹ 1.00 /share
25 Jul 2025 685.85 846.55
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 682.75 685.85
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 581.00 651.05
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 601.65 623.10
02 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Aug 2024 471.55 505.05
24 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
24 Jul 2024 469.50 487.45
20 Jul 2023 DIVIDEND Dividend
₹ 1.00 /share
20 Jul 2023 289.05 328.75

Announcements

Update On Consummation Of Shrimann Superspecialty Hospital Transaction22 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
Intimation On Operation And Maintenance Services Agreement With Gleneagles Healthcare India Private Limited2 days ago
Update On SRL Trademarks4 days ago
Intimation On Tax Deduction At Source (TDS)/Withholding Tax On Dividend8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Letters Contain The Weblink To Access The Annual Report Of Financial Year 2024-25Jul 14, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 14, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendJul 14, 2025
Record Date Fixed For Dividend PaymentJul 14, 2025
Please Find Enclosed The Intimation Of Date Of Closure Of Register Of Members & Share Transfer BookJul 14, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 14, 2025
Regulation 53 (1) Annual Report.Jul 14, 2025
Reg. 34 (1) Annual Report.Jul 14, 2025
Intimation Of Notice Of 29Th AGM Of Fortis Healthcare Limited To Be Held On August 11 2025Jul 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 11, 2025
Disclosure On Completion Of Term Of Independent DirectorJun 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 27, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 27, 2025
Closure of Trading WindowJun 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Updates On Acquisition - Shrimann HospitalMay 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Statement Of Utilization And Deviation Or Variation In The Use Of Proceeds Of Issue Of Listed Non-Convertible Debentures (Ncds)May 20, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).May 20, 2025
Compliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 And Other Relevant Provisions.May 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
Compliances-Reg. 54 - Asset Cover details May 20, 2025
Revision In Policies.May 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Appointment Of Secretarial Auditors And Cost Auditors.May 20, 2025
Corporate Action-Board approves DividendMay 20, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
Reschedule Of Investors/ Ananlysts CallMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025

Technical Indicators

RSI(14)
Neutral
70.17
ATR(14)
Less Volatile
20.77
STOCH(9,6)
Overbought
86.75
STOCH RSI(14)
Overbought
95.91
MACD(12,26)
Bullish
3.72
ADX(14)
Strong Trend
29.33
UO(9)
Bearish
62.01
ROC(12)
Uptrend And Accelerating
7.09
WillR(14)
Overbought
-3.40

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Arbitrage Fund Direct-Growth
0.39%
3366600
0.39%
0.39%
Invesco India Arbitrage Fund Direct-Growth
0.59%
1784825
0.59%
0.59%
Mirae Asset Large & Midcap Fund Direct-Growth
0.00%
-923041
-0.17%
-0.49%
Mirae Asset Midcap Fund Direct - Growth
0.76%
-827482
-0.31%
-0.34%
ICICI Prudential Equity Arbitrage Direct-Growth
0.15%
567300
0.15%
0.15%
Mirae Asset Arbitrage Fund Direct - Growth
0.94%
380525
0.94%
0.94%
Kotak Large & Midcap Fund Direct-Growth
0.84%
300000
0.13%
0.17%
Nippon India Growth Mid Cap Fund Direct- Growth
2.75%
285587
0.21%
0.13%
Nippon India Arbitrage Fund Direct-Growth
0.16%
269700
0.15%
0.16%
Mirae Asset Healthcare Fund Direct - Growth
3.27%
211430
0.82%
1.07%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
2.42%
154093
0.33%
0.31%
SBI Arbitrage Opportunities Fund Direct-Growth
0.03%
147250
0.03%
0.03%
Aditya Birla Sun Life Arbitrage Fund Direct-Growth
0.05%
137950
0.05%
0.05%
Tata Nifty Midcap 150 Momentum 50 Index Fund Direct - Growth
2.48%
-111622
-0.72%
-0.79%
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct - Growth
2.48%
-103964
-0.71%
-0.80%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
1.26%
100000
1.26%
1.26%
WhiteOak Capital Mid Cap Fund Direct - Growth
2.05%
86643
0.27%
0.37%
SBI Healthcare Opportunities Fund Direct Plan-Growth
3.30%
-80000
0.08%
0.16%
Bandhan Midcap Fund Direct-Growth
1.14%
68056
0.35%
1.14%
Edelweiss Arbitrage Fund Direct-Growth
0.03%
62775
0.03%
0.03%
Kotak Healthcare Fund Direct - Growth
3.15%
60000
1.20%
1.16%
Nippon India Nifty 500 Momentum 50 Index Fund Direct-Growth
1.91%
-50072
-0.37%
-0.43%
Aditya Birla Sun Life India GenNext Direct Fund-Growth
1.01%
-50000
0.02%
0.04%
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth
1.92%
-39528
-0.37%
-0.42%
Baroda BNP Paribas Retirement Fund Direct - Growth
0.71%
35000
0.71%
0.71%

About Fortis Healthcare

Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years, 16 days)
Chairperson NameLeo Puri